Basic Information
| LncRNA/CircRNA Name | lnc-TLN2-4:1 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR etc. |
| Sample | GC tissue versus matched normal tissue,cell lines (AGS, MKN45, MGC803, BGC823, SGC7901, and MKN74) |
| Expression Pattern | down-regulated |
| Function Description | Lnc-TLN2-4:1 Expression Is Frequently Decreased in GC Tissues Compared with Matched Normal Tissues and Is Associated with GC Metastasis |
| Pubmed ID | 32256587 |
| Year | 2020 |
| Title | Long Noncoding RNA Lnc-TLN2-4:1 Suppresses Gastric Cancer Metastasis and Is Associated with Patient Survival |
External Links
| Links for lnc-TLN2-4:1 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |